<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1877405A-70A7-4118-ACB3-5B5104442340"><gtr:id>1877405A-70A7-4118-ACB3-5B5104442340</gtr:id><gtr:firstName>Jared</gtr:firstName><gtr:surname>Simpson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/99E38428-4F5A-4B0A-A962-7B4B313D492A"><gtr:id>99E38428-4F5A-4B0A-A962-7B4B313D492A</gtr:id><gtr:firstName>Oliver</gtr:firstName><gtr:surname>Pybus</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4466027A-D38D-409B-9089-1B9EECDC1C8A"><gtr:id>4466027A-D38D-409B-9089-1B9EECDC1C8A</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Loman</gtr:surname><gtr:orcidId>0000-0002-9843-8988</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/78BDD550-E2BA-4E71-8147-ACCD2CC69C8A"><gtr:id>78BDD550-E2BA-4E71-8147-ACCD2CC69C8A</gtr:id><gtr:firstName>Nuno</gtr:firstName><gtr:surname>Faria</gtr:surname><gtr:orcidId>0000-0001-8839-2798</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/76B95979-9CBD-452B-BDF5-56AA6F5F3DF5"><gtr:id>76B95979-9CBD-452B-BDF5-56AA6F5F3DF5</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Rambaut</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D3CF8793-5BB6-451D-85F7-B76822F67BED"><gtr:id>D3CF8793-5BB6-451D-85F7-B76822F67BED</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:surname>Loose</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15100"><gtr:id>EAC32449-AB94-4D1A-825C-F91ECA632B0B</gtr:id><gtr:title>Zika: Open genomic surveillance of Zika virus in Brazil using a novel portable real-time sequencing device</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15100</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>A major epidemic of Zika virus (ZIKV) is ongoing in Latin America. Critically, there is
evidence for an association between infection with ZIKV and both microcephaly in newborns
and Guillain-Barr&amp;eacute; syndrome. Currently there is a paucity of complete genome sequences for
this virus, in part due to difficulties in transporting material outside of Brazil for sequencing,
hindering attempts to determine virus origins, epidemiology and any genomic basis to
microcephaly. We have recently established real-time portable genome sequencing using the
Oxford Nanopore MinION device, and successfully used this to characterize Ebola virus
genetic diversity in Guinea during the 2014-2015 outbreak [1]. We propose to extend this
ground-breaking achievement to ZIKV by establishing two portable genome sequencing
laboratories in Brazil. Through collaboration with the Oswaldo Cruz Foundation (FIOCRUZ)
and the Instituto Evandro Chagas public health laboratory in Brazil we will sequence 750
complete genomes of ZIKV, covering a broad geographical region including historical
samples, and from patients with a range of clinical presentations. These novel genomic data
will provide key information on how and when ZIKV was introduced to Brazil, the pattern and
determinants of spread through the country and to neighbouring localities, the extent of
genetic diversity (of importance to vaccine and diagnostic design), and whether there are any
associations between changes in the virus genome and the likelihood of ZIKV complications
such as microcephaly. Crucially these data will provide a surveillance framework for tracking
further spread into other geographic regions. In common with our previous efforts, this effort
will serve as a beacon for open science during a public health emergency [1-4]. Data will be
subject to open release as it is generated.</gtr:technicalSummary><gtr:fund><gtr:end>2017-10-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-31</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>38502</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>Global Outbreak Alert &amp; Response Network (GOARN)</gtr:department><gtr:description>World Health Organization Global Advisory Alert and Response Network - Technical Expert/Outbreak Response Participation</gtr:description><gtr:id>09E0A1AA-44EA-49C5-BD46-EF3D763CA9D6</gtr:id><gtr:impact>In the past weeks this has included serving in an advisory function to support an outbreak of necrotising cellulitis in Sao Tome. We provided rapid response sequencing facility, in collaboration with Ian Goodfellow (University of Cambridge) to the island and provided real-time pathogen diagnostics and epidemiology using nanopore sequencing.</gtr:impact><gtr:outcomeId>58ca8baa04df59.93878075-1</gtr:outcomeId><gtr:partnerContribution>WHO are the recognised international agency responsible for the management and containment of outbreaks and epidemics.</gtr:partnerContribution><gtr:piContribution>We have been included as technical experts on next-generation molecular diagnostics (by sequencing) to assist the WHO in outbreak and epidemic response when required in-country.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:currCode>BRL</gtr:currCode><gtr:currCountryCode>Brazil</gtr:currCountryCode><gtr:currLang>pt_BR</gtr:currLang><gtr:description>ZIBRA 2 - ZIKV in Brazil Real-Time Analysis - Second Round</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Council for Scientific and Technological Development (CNPq)</gtr:fundingOrg><gtr:fundingRef>MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit/No.14/2016 - Preventing and Combating Zika Virus</gtr:fundingRef><gtr:id>C351CCB2-D375-46D7-AB31-330B6B9DD7A2</gtr:id><gtr:outcomeId>58ca74417d77d4.26802797</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A7C7504E-8065-4D41-B538-F5D92669E519</gtr:id><gtr:title>Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6680c159d84533558ccb13e96ec45efc"><gtr:id>6680c159d84533558ccb13e96ec45efc</gtr:id><gtr:otherNames>Quick J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58ca764a2a1c05.02866092</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CBAD5DD-8F1C-43FE-A738-24A63ED6D0CF</gtr:id><gtr:title>Genomic epidemiology reveals multiple introductions of Zika virus into the United States.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac3ab78ab15795e4e793003b1cc69dff"><gtr:id>ac3ab78ab15795e4e793003b1cc69dff</gtr:id><gtr:otherNames>Grubaugh ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5aa6e38aab75f3.04067094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C2AC650-8000-4970-B33F-5B83163A3569</gtr:id><gtr:title>Mobile real-time surveillance of Zika virus in Brazil.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3836941586349b96d92e748acb29da1"><gtr:id>a3836941586349b96d92e748acb29da1</gtr:id><gtr:otherNames>Faria NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>58c5b2851f78b3.10052880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD6D5DF-8433-4944-A5A5-76B64CF7DD6E</gtr:id><gtr:title>Establishment and cryptic transmission of Zika virus in Brazil and the Americas.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3836941586349b96d92e748acb29da1"><gtr:id>a3836941586349b96d92e748acb29da1</gtr:id><gtr:otherNames>Faria NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5aa6e38b031946.44789915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1D60A0C-8E21-4B04-AA93-1A61903A0675</gtr:id><gtr:title>First Complete Genome Sequences of Zika Virus Isolated from Febrile Patient Sera in Ecuador.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bc1c61ff35278cf320b107e26f3e162"><gtr:id>7bc1c61ff35278cf320b107e26f3e162</gtr:id><gtr:otherNames>M?rquez S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c5b283adf706.31197206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16043E98-A7FB-4963-A60B-119D2257868E</gtr:id><gtr:title>Multiple introductions of Zika virus into the United States revealed through genomic epidemiology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/921c0ca78c6afe3f40aeba4b9dc11967"><gtr:id>921c0ca78c6afe3f40aeba4b9dc11967</gtr:id><gtr:otherNames>Grubaugh N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58ca76f889a833.02030688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C882AABC-D312-482C-8429-76F563034055</gtr:id><gtr:title>Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6680c159d84533558ccb13e96ec45efc"><gtr:id>6680c159d84533558ccb13e96ec45efc</gtr:id><gtr:otherNames>Quick J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>5aa6e38a727540.69834731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6F81A0B-862E-4B07-80C0-C0490B21565A</gtr:id><gtr:title>Epidemic establishment and cryptic transmission of Zika virus in Brazil and the Americas</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68d8a6defc1b2c3d27a85dcece946819"><gtr:id>68d8a6defc1b2c3d27a85dcece946819</gtr:id><gtr:otherNames>Faria N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58ca75a61ba195.66562786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C177B8AC-004C-49B7-BF5A-B0D51B52F173</gtr:id><gtr:title>Towards a genomics-informed, real-time, global pathogen surveillance system.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78bc5d6e018756713c7815b4c4129c59"><gtr:id>78bc5d6e018756713c7815b4c4129c59</gtr:id><gtr:otherNames>Gardy JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1471-0056</gtr:issn><gtr:outcomeId>5aa6e3ef9d7347.91524757</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15100</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes><gtr:rcukProgramme><gtr:id>C11BDEA9-7D9D-4728-B6A9-31032921B328</gtr:id><gtr:text>Newton</gtr:text></gtr:rcukProgramme></gtr:rcukProgrammes></gtr:project></gtr:projectComposition></gtr:projectOverview>